171 related articles for article (PubMed ID: 32160210)
1. Intranasal administration of dantrolene increased brain concentration and duration.
Wang J; Shi Y; Yu S; Wang Y; Meng Q; Liang G; Eckenhoff MF; Wei H
PLoS One; 2020; 15(3):e0229156. PubMed ID: 32160210
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice.
Shi Y; Zhang L; Gao X; Zhang J; Ben Abou M; Liang G; Meng Q; Hepner A; Eckenhoff MF; Wei H
J Alzheimers Dis; 2020; 76(4):1375-1389. PubMed ID: 32623395
[TBL] [Abstract][Full Text] [Related]
3. Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
Vera R; Hong N; Jiang B; Liang G; Eckenhoff MF; Kincaid HJ; Browne V; Chellaraj V; Gisewhite D; Greenberg M; Ranjan S; Zhu G; Wei H
J Alzheimers Dis; 2024; 98(2):549-562. PubMed ID: 38393915
[TBL] [Abstract][Full Text] [Related]
4. Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats.
Fuchs H; Kishimoto W; Gansser D; Tanswell P; Ishiguro N
Drug Metab Dispos; 2014 Oct; 42(10):1761-5. PubMed ID: 25053619
[TBL] [Abstract][Full Text] [Related]
5. Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease.
Wong LR; Ho PC
J Pharm Pharmacol; 2018 Jan; 70(1):59-69. PubMed ID: 29034965
[TBL] [Abstract][Full Text] [Related]
6. Penetration of thyroliberin in the blood and brain regions at intranasal or intravenous administration.
Shevchenko KV; Vyunova TV; Radilov AS; Andreeva LA; Nagaev IY; Shevchenko VP; Rembovsky VR; Myasoedov NF
Dokl Biochem Biophys; 2015; 465():436-9. PubMed ID: 26728743
[TBL] [Abstract][Full Text] [Related]
7. Effects of intranasal dantrolene nanoparticles on brain concentration and behavior in PS19 tau transgenic mice.
Vera R; Hong N; Jiang B; Liang G; Eckenhoff MF; Kincaid HJ; Browne V; Chellaraj V; Gisewhite D; Greenberg M; Ranjan S; Zhu G; Wei H
Res Sq; 2023 May; ():. PubMed ID: 37214948
[TBL] [Abstract][Full Text] [Related]
8. A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration.
Gonçalves J; Silva S; Gouveia F; Bicker J; Falcão A; Alves G; Fortuna A
Int J Pharm; 2021 Jan; 593():120161. PubMed ID: 33307160
[TBL] [Abstract][Full Text] [Related]
9. Effect of feed restriction on plasma dantrolene concentrations in horses.
McKenzie EC; Garrett RL; Payton ME; Riehl JH; Firshman AM; Valberg SJ
Equine Vet J Suppl; 2010 Nov; (38):613-7. PubMed ID: 21059069
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic evaluation of oral dantrolene in the dog.
Haraschak JL; Langston VC; Wang R; Riggs C; Fellman C; Ross MK; Bulla C; Lunsford K; Mackin A; Archer T
J Vet Pharmacol Ther; 2014 Jun; 37(3):286-94. PubMed ID: 24219828
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of dantrolene sodium in horses.
Court MH; Engelking LR; Dodman NH; Anwer MS; Seeler DC; Clark M
J Vet Pharmacol Ther; 1987 Sep; 10(3):218-26. PubMed ID: 3656508
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and brain penetration study of chlorogenic acid in rats.
Kumar G; Paliwal P; Mukherjee S; Patnaik N; Krishnamurthy S; Patnaik R
Xenobiotica; 2019 Mar; 49(3):339-345. PubMed ID: 29480050
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent and long-term cerebroprotective effects of intranasal delivery of progesterone after ischemic stroke in male mice.
Fréchou M; Zhu X; Liere P; Pianos A; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2020 Jun; 170():108038. PubMed ID: 32151648
[TBL] [Abstract][Full Text] [Related]
14. Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.
Hanson LR; Roeytenberg A; Martinez PM; Coppes VG; Sweet DC; Rao RJ; Marti DL; Hoekman JD; Matthews RB; Frey WH; Panter SS
J Pharmacol Exp Ther; 2009 Sep; 330(3):679-86. PubMed ID: 19509317
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection.
Fréchou M; Zhang S; Liere P; Delespierre B; Soyed N; Pianos A; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2015 Oct; 97():394-403. PubMed ID: 26079443
[TBL] [Abstract][Full Text] [Related]
16. Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration.
Yang ZZ; Zhang YQ; Wang ZZ; Wu K; Lou JN; Qi XR
Int J Pharm; 2013 Aug; 452(1-2):344-54. PubMed ID: 23680731
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid can be used as a surrogate to assess brain exposures of breast cancer resistance protein and P-glycoprotein substrates.
Xiao G; Black C; Hetu G; Sands E; Wang J; Caputo R; Rohde E; Gan LS
Drug Metab Dispos; 2012 Apr; 40(4):779-87. PubMed ID: 22266779
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic intranasal dantrolene on nasal mucosa morphology in mice.
Jiang B; Shi Y; Abou MB; Xu L; Liang G; Wei H
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):198-203. PubMed ID: 35048995
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the safety and brain-related tissues distribution characteristics of TAT-HaFGF via intranasal administration.
Xu J; Xiang Q; Su J; Yang P; Zhang Q; Su Z; Xiao F; Huang Y
Biol Pharm Bull; 2014; 37(7):1149-57. PubMed ID: 24989006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
